---
schema_version: "secwatch.filing_event.v1"
accession: "0000075252-22-000055"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2022-11-02T23:59:59+00:00"
generated_at: "2026-06-22T16:00:52.236117+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Owens & Minor Q3 GAAP EPS $0.16 vs $0.58 YoY; adjusted EBITDA margin up 140 bps

## Summary
- GAAP net income $12.5M ($0.16 EPS) vs $44.1M ($0.58 EPS) in Q3 2021; adjusted EPS $0.41 vs $0.74.
- Revenue $2,497M, nearly flat YoY; adjusted EBITDA $127M, margin up 140 bps.
- Patient Direct segment revenue grew 142% (11.4% pro forma for Apria); CPAP opportunities captured.
- Products & Healthcare Services segment challenged by delayed customer reorders; accelerating key initiatives.
- Generated $69M cash from operations in the quarter.

## SEC filing metadata
- accession: 0000075252-22-000055
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2022-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000007525222000055/0000075252-22-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000007525222000055/omi-20221102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000075252-22-000055
- JSON: https://secwatch.observer/filing/0000075252-22-000055.json
- Plain text: https://secwatch.observer/filing/0000075252-22-000055.txt

## Key facts
- Earnings Releases
  ACCENDRA HEALTH INC/VA/ reported the third quarter ended September 30, 2022 results: revenue $2,497, net income $12.5, EPS $0.16.
  - Period: the third quarter ended September 30, 2022
  - Revenue: $2,497
  - Net income: $12.5
  - EPS: $0.16
  - Result: reported results
  source text: as our execution and market conditions improve,” Pesicka concluded. Financial Summary (1) ($ in millions, except per share data) 3Q22 3Q21 YTD 2022 YTD 2021 Revenue $2,497 $2,502 $7,404 $7,318 Operating income, GAAP $60.2 $62.9 $196.4 $306.5 Adj. Operating Income, Non-GAAP $83.4 $79.3 $301.9 $357.5 Net income, GAAP $12.5 $44.1 $80.4 $179.6 Adj. Net
  evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000007525222000055/0000075252-22-000055-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.